AnaBios is pleased to announce that Dr. Kristine Griffett, Assistant Professor of Pharmacology at Auburn University, is the winner of our third annual Translational Research Grant Award. Dr. Griffett will obtain up to $15,000 in AnaBios’ high-quality human hepatocytes to validate her team’s pre-clinical data on liver toxicity, gene regulation and metabolic health. Dr. Griffett’s research […]
SAN DIEGO, CA – April 4, 2023 – AnaBios Corporation today announced the acquisition of Cell Systems, a human primary cell and cell culture media company located in Kirkland, Washington. The purchase of Cell Systems will further enhance AnaBios’ unique human tissue and cells portfolio and help scientists expedite drug discovery and further their understanding of […]
The agreement will drive the discovery of more effective treatments for cardiovascular disease and development of safer drugs with the pre-clinical implementation of advanced human heart models. SAN DIEGO, CA – February 14, 2023 – AnaBios, a pre-clinical contract research organization that provides ex vivo human platforms to de-risk new drugs, today announced a technology transfer […]
SAN DIEGO, CA – January 30, 2023 – AnaBios is pleased to announce the redesign of their website describing their human tissue platform offerings, including off-the-shelf and custom tissue samples from their industry-leading biorepository, as well as functional assays across the peripheral nervous, central nervous and cardiovascular systems.AnaBios has long been a leader in providing high […]
Alpenglow Biosciences recently created new 3D images of human DRG samples from AnaBios using their unique version of light sheet microscopy. Staining: computation H&E (nuclei: ToPro3, protein: Eosin) Microscope Meta-Data Zoom image: 638 nm Excitation – To-PRO-3; 561 nm excitation – Eosin; 41.3 GB raw data; 0.3 x 0.25 x 0.25 mm X,Y,Z dimensions; Scan time: […]
SAN DIEGO, CA – November 8, 2022 – AnaBios today announced the inaugural Translational Research Conference to be held February 27-28, 2023 in San Diego, California. The conference will gather pharmaceutical, biotech and academic scientists from around the world to share recent advances in translational sciences designed to help improve successful clinical outcomes in humans. “AnaBios […]
Najah Abi-Gerges, Ph.D., Vice President of Research & Development at AnaBios, was recently named a new Associate Editor of the Cardiac Electrophysiology section of Frontiers in Physiology, the second most-cited journal in its field with more than 200,000 citations.Dr. Abi-Gerges holds a MSc in Physiology and Pharmacology from the University of Poitiers (France) and a Ph.D. […]
AnaBios is pleased to announce that University of Florence professor Romina Nassini, BSc, Ph.D., is the winner of our second annual Translational Research Grant Award. Dr. Nassini will obtain up to $15,000 in AnaBios’ high-quality human tissue samples to study different expressions of proinflammatory mediator receptors in the human peripheral and central nervous systems. Dr. […]
SAN DIEGO, CA – June 7, 2022 – AnaBios Corporation, a leading preclinical contract research organization (CRO) that focuses on translational research with unique capabilities to measure drug activity directly in human tissue, today announced an investment from Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and […]
How long have you worked in the life sciences industry and why did you choose this field? I started my career in the life sciences industry back in 2013 through an entrepreneurship experience. I chose this field following my PhD as a natural way to bridge science and marketing. I am a scientist by training, […]